MarketCapExport financials
Applied DNA Sciences (APDN)
The export includes the complete available history of financial statements and ratios. Numbers are provided in full, without million or billion abbreviations, in their original reporting units.
CSV downloads as a ZIP archive with one file for each report and frequency.
Facebook
X
Telegram
Applied DNA Sciences Income Statement 2026-2009 | APDN
Brief overview of income trends at Applied DNA Sciences
The overview follows changes across a five-year period. Revenue at Applied DNA Sciences moved from $1.9 million in 2020 to $2.1 million in 2025. Overall revenue changed by +10.6%, equal to an annualized rate of about 2%. The scale of the core business was largely unchanged.
Gross profit was $1.2 million at the start and $839 thousand at the end of the period (−30.7%). Cost of revenue developed less favorably than sales and pressured gross profitability. At the margin level, the figure shifted from 62.7% to 39.3%. Weakening gross profitability reduces the quality of the top-line trend.
The operating result measured by EBITDA moved from −12.2 million dollars to −15.7 million dollars, or −27.9%. Changes in revenue did not translate into comparable EBITDA performance. At the operating-margin level, the figure shifted from −634.2% to −732.9%. The margin contraction indicates weaker operating efficiency.
The final result was −$13 million initially and −$15.2 million in the final year. The negative result deepened, showing weaker final efficiency.
Financial takeaway
Signs of deterioration dominate the five-year picture. Caution is warranted because of a softer top-line trend, a narrow EBITDA buffer and a declining EBITDA margin. Further direction will depend on top-line growth, operating profitability, and net income.
Annual Income Statement Applied DNA Sciences
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
- | - | 1.22 K | 732 K | 12.9 M | 27.7 M | 30.2 M | 184 K | 33.3 M | 66.7 M | 67.3 M | 65.1 M | 80.8 M | 91.5 M | 109 M | 26.4 M | - | - |
Shares |
9.74 M | 518 K | 5.29 K | 654 K | 8.97 M | 6.92 M | 3.92 M | 23 K | 737 K | 659 K | 592 K | 473 K | 337 K | 293 K | 240 K | 157 K | 346 M | - |
Historical Prices |
- | - | 0.23 | 1.12 | 1.44 | 4.02 | 5.1 | 4.19 | 16 | 63.6 | 74 | 130 | 116 | 384 | 504 | 144 | - | - |
Net Income |
-6.67 M | -15.2 M | -6.99 M | -9.95 M | -8.27 M | -14.3 M | -13 M | -8.62 M | -11.7 M | -12.9 M | -12.2 M | -11.9 M | -13.1 M | -17.7 M | -7.15 M | -10.5 M | -7.91 M | - |
Revenue |
1.02 M | 2.14 M | 2.11 M | 13.4 M | 18.2 M | 9.03 M | 1.93 M | 5.39 M | 3.9 M | 4.75 M | 4.19 M | 9.01 M | 2.72 M | 2.04 M | 1.85 M | 969 K | - | - |
Cost of Revenue |
197 K | 1.3 M | 1.14 M | 7.83 M | 13.1 M | 4.54 M | 721 K | 878 K | 1.21 M | 1.08 M | 1.17 M | 384 K | - | - | - | - | - | - |
Gross Profit |
827 K | 839 K | 975 K | 5.53 M | 5.05 M | 4.48 M | 1.21 M | 4.51 M | 2.7 M | 3.67 M | 3.44 M | - | - | - | 1.85 M | 969 K | - | - |
Operating Income |
-6.75 M | -16 M | -13.7 M | -11 M | -14 M | -13.3 M | -12.5 M | -9.12 M | -11.6 M | -12.8 M | -12.2 M | -7.85 M | -12.3 M | -10.2 M | -6.51 M | -8.06 M | -7.12 M | - |
Interest Expense |
81.7 K | -107 K | -8.88 K | 642 | -47.3 K | -8.76 K | -378 K | -43.3 K | -37 K | -38.4 K | 12.9 K | -28.3 K | 124 K | -1.27 K | 643 K | 2.46 M | 793 K | - |
EBITDA |
-6.68 M | -15.7 M | -13.2 M | -9.59 M | -12.7 M | -12.5 M | -12.2 M | -8.73 M | -11.1 M | -11.9 M | -11.5 M | -7.36 M | -11.8 M | -9.85 M | -6.19 M | -7.69 M | -6.75 M | - |
Operating Expenses |
7.58 M | 16.9 M | 14.6 M | 16.5 M | 19 M | 17.8 M | 13.7 M | 13.6 M | 14.3 M | 16.5 M | 15.6 M | 16.9 M | 15 M | 12.2 M | 8.36 M | 9.03 M | 7.64 M | - |
General and Administrative Expenses |
2.59 M | 10.9 M | 11 M | 12.8 M | 15.1 M | 12.8 M | 10.1 M | 10.3 M | 11 M | 13.3 M | 11.2 M | 14.7 M | 13.2 M | 11.2 M | 7.62 M | 8.39 M | 7.19 M | - |
Annual performance
Select metrics to display
All numbers in USD currency
Quarterly Income Statement Applied DNA Sciences
| 2026-Q3 | 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
572 K | 9.74 M | 8.94 M | 8.94 M | 1.66 M | 572 K | 1.77 M | 42 K | 13.8 K | 1.61 K | 17.4 K | 684 K | 683 K | 645 K | 12.9 M | 12.9 M | 12.9 M | 8.98 M | 8.08 M | 7.49 M | 6.72 M | 7.24 M | 7.24 M | 5.46 M | 3.51 M | 4.58 M | 3.76 M | 2.38 M | 874 K | 953 K | 2.38 M | 762 K | 29.3 M | 30.1 M | 30.5 M | 27.7 M | 26 M | 26.4 M | 27.7 M | 25.4 M | 23.6 M | 24.1 M | 25.4 M | 22.5 M | 18.1 M | 21.4 M | 22.5 M | 15.5 M | 13.4 M | 13.6 M | 15.5 M | 13.2 M | 684 M | 721 M | 790 M | 650 M | 556 M | 595 M | 650 M | 490 M | 351 M | 352 M | 351 M |
Net Income |
-19.4 M | -6.67 M | -18.6 M | -18.6 M | - | -3.95 M | -3.3 M | -2.64 M | - | 1.88 M | -4.47 M | -1.11 M | - | -3.1 M | 551 K | -3.84 M | -7.6 M | -1.12 M | -1.76 M | -4.72 M | -9.78 M | -3.45 M | -1.52 M | -4.81 M | -8.9 M | -3.29 M | -2.95 M | -2.66 M | -7.4 M | -1.48 M | -2.66 M | -3.23 M | -3.23 M | -3.23 M | -3.23 M | -3.18 M | -10 M | -2.61 M | -3.18 M | -3.96 M | -9.76 M | -3.37 M | -3.96 M | -2.93 M | -11.4 M | -1.67 M | -2.93 M | -7.83 M | -11 M | -1.92 M | -7.83 M | -6.29 M | -14 M | -2.14 M | -6.29 M | -8.7 M | -5.38 M | -1.43 M | -8.7 M | -2.41 M | -6.1 M | -2.15 M | -2.41 M |
Revenue |
304 K | 1.02 M | 565 K | 565 K | - | 304 K | 983 K | 870 K | - | 473 K | 930 K | 891 K | - | 2.92 M | 4.41 M | 5.26 M | 14.6 M | 4.3 M | 6.15 M | 4.17 M | 5.99 M | 1.7 M | 2.67 M | 1.62 M | 1.62 M | 432 K | 1.62 M | 634 K | 3.72 M | 2.05 M | 634 K | 884 K | 2.71 M | 1.02 M | 1.04 M | 648 K | 3.61 M | 1.8 M | 905 K | 903 K | 2.55 M | 653 K | 903 K | 1.32 M | 5.03 M | 2.27 M | 1.32 M | 1.24 M | 2.08 M | 841 K | 1.24 M | 597 K | 1.31 M | 645 K | 597 K | 318 K | 1.56 M | 529 K | 318 K | 517 K | 688 K | 230 K | 517 K |
Cost of Revenue |
299 K | 197 K | 250 K | 250 K | - | 299 K | 613 K | 264 K | - | 230 K | 634 K | 660 K | - | 1.65 M | 2.6 M | 2.89 M | 9.97 M | 3.26 M | 3.66 M | 3.06 M | 2.57 M | 1.12 M | 941 K | 516 K | 566 K | 155 K | 243 K | 232 K | 558 K | 271 K | 232 K | 153 K | 956 K | 253 K | 153 K | 331 K | 805 K | 232 K | 331 K | 275 K | 736 K | 181 K | 275 K | 184 K | 129 K | 129 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
5.13 K | 827 K | 315 K | 315 K | - | 5.13 K | 371 K | 606 K | - | 243 K | 296 K | 231 K | - | 1.27 M | 1.81 M | 2.38 M | 4.64 M | 1.04 M | 2.49 M | 1.11 M | 3.42 M | 584 K | 1.73 M | 1.1 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-3.69 M | -6.75 M | -18.7 M | -18.7 M | - | -3.69 M | -3.46 M | -2.98 M | - | -3.31 M | -3.62 M | -3.79 M | - | -2.86 M | -2.7 M | -1.22 M | -9.6 M | -2.86 M | -2.15 M | -4.71 M | -8.8 M | -3.44 M | -2.32 M | -2.97 M | -8.48 M | -3.19 M | -2.97 M | -2.61 M | -7.26 M | -1.43 M | -2.61 M | -3.2 M | -8.18 M | -2.87 M | -3.2 M | -3.17 M | -9.98 M | -2.6 M | -3.17 M | -3.95 M | -9.79 M | -3.42 M | -3.95 M | -2.92 M | -7.37 M | -1.67 M | -2.92 M | -3.82 M | -9.43 M | -2.49 M | -3.82 M | -3.81 M | -7.82 M | -2.84 M | -3.81 M | -2.37 M | -4.74 M | -1.43 M | -2.37 M | -1.81 M | -4.28 M | -1.49 M | -1.81 M |
Interest Expense |
40.3 K | 81.7 K | 92.6 K | 92.6 K | - | -531 | -3.1 K | -20.2 K | - | -103 | 4.58 K | -13.5 K | - | -3.47 K | 661 | 8.85 K | -160 K | -26.4 K | -2.27 K | -14.6 K | -52.4 K | -8.58 K | -54.9 K | -53.9 K | -335 K | -72.7 K | -53.9 K | -22.2 K | -31.4 K | -8.1 K | -22.2 K | -6.55 K | -36.7 K | -21.4 K | -6.55 K | -9.08 K | -26.6 K | -8.76 K | -9.08 K | -9.37 K | 19.6 K | 52.7 K | -9.37 K | -8.59 K | -16.9 K | -3.72 K | -8.59 K | -3.68 K | 130 K | 52.3 K | -3.68 K | 155 K | 738 | -333 | -405 | - | 643 K | 2.42 K | 42.8 K | 598 K | 1.82 M | 664 K | 598 K |
EBITDA |
-3.69 M | -6.68 M | -18.7 M | -18.7 M | - | - | - | -2.94 M | - | - | - | -3.49 M | - | - | - | -880 K | -8.64 M | -2.86 M | -2.15 M | -4.39 M | -8.25 M | -3.14 M | -2.12 M | -2.88 M | -8.28 M | -3.05 M | -2.88 M | -2.54 M | -7.03 M | -1.2 M | -2.54 M | -3.06 M | -7.75 M | -2.56 M | -3.06 M | -3.02 M | -9.49 M | -2.28 M | -3.02 M | -3.79 M | -9.23 M | -3.03 M | -3.79 M | -2.7 M | -7.01 M | -1.44 M | -2.7 M | -3.71 M | -9.1 M | -2.27 M | -3.71 M | -3.71 M | -7.72 M | -2.8 M | -3.71 M | -2.35 M | -4.44 M | -1.23 M | -2.35 M | -1.71 M | -4 M | -1.31 M | -1.71 M |
Operating Expenses |
3.7 M | 7.58 M | 19 M | 19 M | - | 3.7 M | 3.83 M | 3.58 M | - | 3.55 M | 3.91 M | 4.02 M | - | 4.13 M | 4.51 M | 3.6 M | 14.2 M | 3.9 M | 4.64 M | 5.82 M | 12.2 M | 4.03 M | 4.05 M | 4.07 M | 9.53 M | 3.47 M | 4.35 M | 3.01 M | 10.4 M | 3.21 M | 3.01 M | 3.93 M | 9.93 M | 3.63 M | 3.93 M | 3.49 M | 12.8 M | 4.17 M | 3.49 M | 4.58 M | 11.6 M | 3.89 M | 4.58 M | 4.06 M | 12.3 M | 3.81 M | 4.24 M | 5.06 M | 11.5 M | 3.33 M | 5.06 M | 4.41 M | 9.13 M | 3.49 M | 4.41 M | 2.69 M | 6.3 M | 1.96 M | 2.69 M | 2.33 M | 4.97 M | 1.72 M | 2.33 M |
General and Administrative Expenses |
2.93 M | 2.59 M | 13.3 M | 13.3 M | - | 2.93 M | 2.98 M | 2.57 M | - | 2.64 M | 3 M | 3.08 M | - | 3.29 M | 3.52 M | 2.63 M | 11.2 M | 3.03 M | 3.57 M | 4.74 M | 9.35 M | 2.88 M | 3.09 M | 3.31 M | 7.25 M | 2.59 M | 3.5 M | 2.37 M | 8.02 M | 2.41 M | 2.37 M | 3.08 M | 7.47 M | 2.88 M | 3.08 M | 2.59 M | 10.5 M | 3.4 M | 2.59 M | 3.9 M | 8.19 M | 2.58 M | 3.9 M | 3.17 M | 10.3 M | 3.22 M | 3.55 M | 4.67 M | 10.1 M | 2.95 M | 4.67 M | 3.85 M | 8.52 M | 3.24 M | 3.85 M | 2.52 M | 5.73 M | 1.75 M | 2.52 M | 2.15 M | 4.53 M | 1.58 M | 2.15 M |
Quarterly performance
Select metrics to display
All numbers in USD currency
The income statement is one of the three key financial reports of a company Applied DNA Sciences (alongside the balance sheet and the cash flow statement). It shows how the company makes money and what its expenses are:
- How much revenue the company earned
- How much it spent on production, personnel, marketing, taxes, etc.
- What profit remained in the end
Analyzing the income statement helps an investor understand whether the business generates stable and growing profits, how effectively the company controls its expenses, and whether it is capable of generating income in the future. Additionally, this analysis shows how the company copes with crises and economic cycles, and allows assessing the potential for stock price growth and dividend payments.
Features- The income statement may include both recurring and one-time items (for example, profit from the sale of assets). It is necessary to separate core metrics from one-off events for accurate analysis.
- Companies often publish interim reports (e.g., quarterly), which allows for more timely tracking of trends.
- A combined analysis of the income statement with the balance sheet and cash flow statement provides a comprehensive view of the company’s financial health.
Reports on the profits and losses of other stocks in the Security protection industry
| Issuer | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|
 |
Allegion plc
ALLE
|
$ 189.55 | -0.51 % | $ 16.3 B |  USA |
 |
SuperCom Ltd.
SPCB
|
$ 8.56 | 0.33 % | $ 39 M |  Israel |
 |
Verra Mobility Corporation
VRRM
|
$ 2.06 | -3.52 % | $ 328 M | USA |
 |
Vivint Smart Home
VVNT
|
- | -0.04 % | $ 2.58 B | USA |
 |
Mistras Group
MG
|
$ 20.18 | 0.1 % | $ 634 M | USA |
 |
Universal Security Instruments
UUU
|
$ 5.29 | 3.73 % | $ 12.7 M | USA |
 |
CompX International
CIX
|
$ 44.43 | 9.42 % | $ 547 M | USA |
 |
The Brink's Company
BCO
|
$ 117.4 | 2.47 % | $ 4.95 B | USA |
 |
Arlo Technologies
ARLO
|
$ 12.26 | 0.95 % | $ 1.28 B | USA |
 |
Brady Corporation
BRC
|
$ 80.02 | 0.13 % | $ 3.78 B | USA |
 |
BIO-key International
BKYI
|
$ 2.37 | -0.84 % | $ 1.58 M | USA |
 |
ADT
ADT
|
$ 9.9 | -0.35 % | $ 7.23 B | USA |
 |
MSA Safety Incorporated
MSA
|
$ 174.56 | 0.86 % | $ 6.85 B | USA |
 |
NL Industries
NL
|
$ 7.15 | -2.32 % | $ 349 M | USA |
 |
Rekor Systems
REKR
|
$ 0.33 | -6.78 % | $ 39.5 M | USA |
 |
Napco Security Technologies
NSSC
|
$ 31.37 | -0.19 % | $ 1.12 B | USA |
 |
Resideo Technologies
REZI
|
$ 19.47 | -2.92 % | $ 2.9 B | USA |
 |
Nxt-ID, Inc.
NXTD
|
- | -7.64 % | $ 22.6 M | USA |
 |
Digital Ally
DGLY
|
- | - | $ 3.09 M | USA |
 |
VerifyMe
VRME
|
$ 7.48 | 10.32 % | $ 94.4 M | USA |